[Therapy with oral antidiabetic drugs].

Alexandra Kautzky-Willer, Monika Lechleitner, Thomas R Pieber, Rudolf Prager, Michael Roden, Thomas C Wascher, Raimund Weitgasser
Author Information
  1. Alexandra Kautzky-Willer: Klinische Abteilung für Endokrinologie und Stoffwechsel, Univ.-Klinik für Innere Medizin III, Medizinische Universität Wien, Wien, Osterreich.

Abstract

Hyperglycemia contributes to morbidity and mortality in diabetic patients. Reaching treatment targets with regard to control of glycemia is thus a central goal in the treatment of diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the practical use of oral antidiabetic drugs according to current scientific evidence.

MeSH Term

Administration, Oral
Austria
Blood Glucose
Diabetes Mellitus, Type 2
Humans
Hypoglycemic Agents
Societies, Medical

Chemicals

Blood Glucose
Hypoglycemic Agents

Word Cloud

Created with Highcharts 10.0.0diabeticpatientstreatmentoralantidiabeticHyperglycemiacontributesmorbiditymortalityReachingtargetsregardcontrolglycemiathuscentralgoalpresentarticlerepresentsrecommendationsAustrianDiabetesAssociationpracticalusedrugsaccordingcurrentscientificevidence[Therapydrugs]

Similar Articles

Cited By